Morten Steensen Selected Research

Ringer's acetate

1/2015	Thromboelastography in patients with severe sepsis: a prospective cohort study.
7/2012	Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.
1/2011	Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Morten Steensen Research Topics

Disease

7	Sepsis (Septicemia) 12/2021 - 01/2011
5	Infections 01/2019 - 07/2008
5	Septic Shock (Toxic Shock Syndrome) 01/2015 - 04/2010
3	Hemorrhage 01/2015 - 01/2011
3	Renal Insufficiency (Renal Failure) 07/2012 - 01/2011
3	Critical Illness (Critically Ill) 01/2012 - 07/2008
2	Bacterial Infections (Bacterial Infection) 01/2023 - 01/2019
2	Superinfection 01/2023 - 01/2019
2	Coinfection 01/2023 - 01/2019
1	Virus Diseases (Viral Diseases) 01/2023
1	COVID-19 01/2023
1	Invasive Candidiasis 12/2021
1	Out-of-Hospital Cardiac Arrest 05/2015
1	Multiple Organ Failure (MODS) 02/2015
1	Neoplasms (Cancer) 05/2013
1	Ventricular Fibrillation 10/2011
1	Hyperkalemia 10/2011
1	Hypersensitivity (Allergy) 01/2011
1	Shock 01/2011
1	Acute Kidney Injury (Acute Renal Failure) 01/2011
1	Pneumonia (Pneumonitis) 11/2009
1	Hypoxia (Hypoxemia) 11/2009
1	Inflammation (Inflammations) 07/2008

Drug/Important Bio-Agent (IBA)

3	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2023 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 07/2008
3	Starch (Cornstarch)IBA 01/2015 - 01/2011
3	Ringer's acetateIBA 01/2015 - 01/2011
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2023 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2012 - 09/2011
2	ProcalcitoninIBA 09/2011 - 07/2008
1	Meropenem (Merrem)FDA LinkGeneric 01/2023
1	MannansIBA 12/2021
1	AntigensIBA 12/2021
1	ThrombomodulinIBA 02/2015
1	Syndecan-1 (Syndecan 1)IBA 02/2015
1	Fibrinogen (Factor I)FDA Link 01/2015
1	Hemoglobins (Hemoglobin)IBA 10/2014
1	Adenine FDA LinkGeneric 05/2013
1	Glucose (Dextrose)FDA LinkGeneric 05/2013
1	Mannitol (Osmitrol)FDA LinkGeneric 05/2013
1	Succinylcholine (Suxamethonium Chloride)FDA LinkGeneric 10/2011
1	Cholinergic ReceptorsIBA 10/2011
1	PotassiumIBA 10/2011
1	BilirubinIBA 09/2011
1	Triglycerides (Triacylglycerol)IBA 09/2011
1	Crystalloid SolutionsIBA 01/2011
1	HES 130-0.4IBA 01/2011
1	Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link 01/2011
1	Colloids (Colloid)IBA 01/2011
1	Oxygen (Dioxygen)IBA 11/2009
1	C-Reactive ProteinIBA 07/2008

Therapy/Procedure

4	Therapeutics 01/2019 - 07/2008
4	Resuscitation 05/2015 - 01/2011
3	Length of Stay 01/2023 - 11/2017
2	Extracorporeal Membrane Oxygenation 01/2023 - 11/2009
2	Renal Replacement Therapy (Therapies, Renal Replacement) 07/2012 - 01/2011
2	Critical Care (Surgical Intensive Care) 01/2012 - 04/2010
2	Mechanical Ventilators (Ventilator) 01/2011 - 11/2009
1	Blood Transfusion (Blood Transfusions) 10/2014
1	Erythrocyte Transfusion 05/2013
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 11/2009